Impact of Eszopiclone on Blood Pressure in Patients With Insomnia and Hypertension (PRYSMA-HTN)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 150 participants.
Also called NCT07018557
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 150 participants
- Registry
-
NCT07018557
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Brazil
- Registry status
- Recruiting
Technical summary
Registry record NCT07018557. Randomized; double masking; primary purpose treatment. Start 2025-06-04 (actual); primary completion 2026-06-01 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Impact of Eszopiclone on Blood Pressure in Patients With Insomnia and Hypertension (PRYSMA-HTN)
- Acronym
- PRYSMA-HTN
- Condition
- Insomnia
- Condition
- Hypertension
- Intervention (Drug)
- Eszopiclone 3 mg
- Intervention (Drug)
- Placebo
- Lead sponsor
- University of Sao Paulo
- Collaborator
- Eurofarma Laboratorios S.A.
Record details
- Record id
cardio:ct-nct07018557- Content hash
fb7ef1c6741dae24b0f2357bd0bb0b477cd119433e557b5c2f9c033a6fa33148